219 related articles for article (PubMed ID: 12832562)
1. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.
Blum D; Galas MC; Pintor A; Brouillet E; Ledent C; Muller CE; Bantubungi K; Galluzzo M; Gall D; Cuvelier L; Rolland AS; Popoli P; Schiffmann SN
J Neurosci; 2003 Jun; 23(12):5361-9. PubMed ID: 12832562
[TBL] [Abstract][Full Text] [Related]
2. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Popoli P; Pintor A; Domenici MR; Frank C; Tebano MT; Pèzzola A; Scarchilli L; Quarta D; Reggio R; Malchiodi-Albedi F; Falchi M; Massotti M
J Neurosci; 2002 Mar; 22(5):1967-75. PubMed ID: 11880527
[TBL] [Abstract][Full Text] [Related]
3. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
Blum D; Gall D; Galas MC; d'Alcantara P; Bantubungi K; Schiffmann SN
J Neurosci; 2002 Oct; 22(20):9122-33. PubMed ID: 12388620
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats.
Popoli P; Betto P; Reggio R; Ricciarello G
Eur J Pharmacol; 1995 Dec; 287(2):215-7. PubMed ID: 8749040
[TBL] [Abstract][Full Text] [Related]
5. Minocycline in phenotypic models of Huntington's disease.
Bantubungi K; Jacquard C; Greco A; Pintor A; Chtarto A; Tai K; Galas MC; Tenenbaum L; Déglon N; Popoli P; Minghetti L; Brouillet E; Brotchi J; Levivier M; Schiffmann SN; Blum D
Neurobiol Dis; 2005 Feb; 18(1):206-17. PubMed ID: 15649711
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
Gianfriddo M; Corsi C; Melani A; Pèzzola A; Reggio R; Popoli P; Pedata F
Brain Res; 2003 Jul; 979(1-2):225-9. PubMed ID: 12850590
[TBL] [Abstract][Full Text] [Related]
7. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
Bizat N; Hermel JM; Boyer F; Jacquard C; Créminon C; Ouary S; Escartin C; Hantraye P; Kajewski S; Brouillet E
J Neurosci; 2003 Jun; 23(12):5020-30. PubMed ID: 12832525
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity.
Leventhal L; Sortwell CE; Hanbury R; Collier TJ; Kordower JH; Palfi S
J Comp Neurol; 2000 Oct; 425(4):471-8. PubMed ID: 10975874
[TBL] [Abstract][Full Text] [Related]
10. Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum.
Dixon AK; Widdowson L; Richardson PJ
J Neurochem; 1997 Jul; 69(1):315-21. PubMed ID: 9202325
[TBL] [Abstract][Full Text] [Related]
11. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
Blum D; Gall D; Cuvelier L; Schiffmann SN
Neuroreport; 2001 Jun; 12(8):1769-72. PubMed ID: 11409756
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor-mediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens.
Queiroz G; Talaia C; Gonçalves J
J Neurochem; 2003 May; 85(3):740-8. PubMed ID: 12694400
[TBL] [Abstract][Full Text] [Related]
13. Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease.
Rossi S; Prosperetti C; Picconi B; De Chiara V; Mataluni G; Bernardi G; Calabresi P; Centonze D
Neurosci Lett; 2006 Dec; 410(1):6-10. PubMed ID: 17070651
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
15. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.
Saba J; López Couselo F; Turati J; Carniglia L; Durand D; de Laurentiis A; Lasaga M; Caruso C
J Neuroinflammation; 2020 Oct; 17(1):290. PubMed ID: 33023623
[TBL] [Abstract][Full Text] [Related]
16. Neuronal adenosine A
Domenici MR; Chiodi V; Averna M; Armida M; Pèzzola A; Pepponi R; Ferrante A; Bader M; Fuxe K; Popoli P
Purinergic Signal; 2018 Sep; 14(3):235-243. PubMed ID: 29770921
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.
Lopes LV; Cunha RA; Kull B; Fredholm BB; Ribeiro JA
Neuroscience; 2002; 112(2):319-29. PubMed ID: 12044450
[TBL] [Abstract][Full Text] [Related]
18. Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.
Lee ST; Chu K; Park JE; Kang L; Ko SY; Jung KH; Kim M
Brain Res; 2006 Nov; 1118(1):199-207. PubMed ID: 16959224
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.
Kodsi MH; Swerdlow NR
Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
Garcia M; Vanhoutte P; Pages C; Besson MJ; Brouillet E; Caboche J
J Neurosci; 2002 Mar; 22(6):2174-84. PubMed ID: 11896157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
